San Diego, CA, United States of America

Floyd E Bloom

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Scripps Research Institute. Active years: 2003.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Floyd E Bloom

Introduction

Floyd E Bloom is a notable inventor based in San Diego, CA. He is recognized for his contributions to the field of neuroscience, particularly in the study of hypothalamic-specific polypeptides. His work has significant implications for understanding appetite and feeding behavior.

Latest Patents

Bloom holds a patent for "Hypothalamus-specific polypeptides." This patent discloses hypocretin polynucleotides and hypocretin polypeptides, along with antibodies, oligonucleotides, diagnostic kits, and therapeutic compositions and methods. Hypocretin, a novel hypothalamic-specific polypeptide, is localized in regions of the hypothalamus that are involved in appetite regulation. The biologically active hypocretin polypeptides produce electrical changes in neurons, lower body temperature, and reduce food intake.

Career Highlights

Throughout his career, Bloom has worked with esteemed organizations such as The Scripps Research Institute and Modgene, LLC. His research has contributed to advancements in understanding the biological mechanisms that govern feeding behavior and energy balance.

Collaborations

Bloom has collaborated with notable colleagues, including J Gregor Sutcliffe and Kaare M Gautvik. These partnerships have furthered research in the field and enhanced the impact of his work.

Conclusion

Floyd E Bloom's innovative research and patent contributions have significantly advanced the understanding of hypothalamic functions related to appetite and feeding behavior. His work continues to influence the field of neuroscience and holds promise for future therapeutic applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…